185 related articles for article (PubMed ID: 29923986)
1. Serelaxin, recombinant human relaxin-2, for heart failure patients: A systematic review and meta-analysis.
Yu L; Cao L; Sun J; Li Z; Yao F; Zhou Y
Medicine (Baltimore); 2018 Jun; 97(25):e11010. PubMed ID: 29923986
[TBL] [Abstract][Full Text] [Related]
2. Effects of Serelaxin in Patients with Acute Heart Failure.
Metra M; Teerlink JR; Cotter G; Davison BA; Felker GM; Filippatos G; Greenberg BH; Pang PS; Ponikowski P; Voors AA; Adams KF; Anker SD; Arias-Mendoza A; Avendaño P; Bacal F; Böhm M; Bortman G; Cleland JGF; Cohen-Solal A; Crespo-Leiro MG; Dorobantu M; Echeverría LE; Ferrari R; Goland S; Goncalvesová E; Goudev A; Køber L; Lema-Osores J; Levy PD; McDonald K; Manga P; Merkely B; Mueller C; Pieske B; Silva-Cardoso J; Špinar J; Squire I; Stępińska J; Van Mieghem W; von Lewinski D; Wikström G; Yilmaz MB; Hagner N; Holbro T; Hua TA; Sabarwal SV; Severin T; Szecsödy P; Gimpelewicz C;
N Engl J Med; 2019 Aug; 381(8):716-726. PubMed ID: 31433919
[TBL] [Abstract][Full Text] [Related]
3. Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial.
Teerlink JR; Cotter G; Davison BA; Felker GM; Filippatos G; Greenberg BH; Ponikowski P; Unemori E; Voors AA; Adams KF; Dorobantu MI; Grinfeld LR; Jondeau G; Marmor A; Masip J; Pang PS; Werdan K; Teichman SL; Trapani A; Bush CA; Saini R; Schumacher C; Severin TM; Metra M;
Lancet; 2013 Jan; 381(9860):29-39. PubMed ID: 23141816
[TBL] [Abstract][Full Text] [Related]
4. Serelaxin a novel treatment for acute heart failure.
Castrini AI; Carubelli V; Lazzarini V; Bonadei I; Lombardi C; Metra M
Expert Rev Clin Pharmacol; 2015; 8(5):549-57. PubMed ID: 26294074
[TBL] [Abstract][Full Text] [Related]
5. A randomized, double-blind, placebo-controlled, multicentre study to assess haemodynamic effects of serelaxin in patients with acute heart failure.
Ponikowski P; Mitrovic V; Ruda M; Fernandez A; Voors AA; Vishnevsky A; Cotter G; Milo O; Laessing U; Zhang Y; Dahlke M; Zymlinski R; Metra M
Eur Heart J; 2014 Feb; 35(7):431-41. PubMed ID: 24255129
[TBL] [Abstract][Full Text] [Related]
6. Serelaxin in acute heart failure: Most recent update on clinical and preclinical evidence.
Ghosh RK; Banerjee K; Tummala R; Ball S; Ravakhah K; Gupta A
Cardiovasc Ther; 2017 Feb; 35(1):55-63. PubMed ID: 27727514
[TBL] [Abstract][Full Text] [Related]
7. Serelaxin in addition to standard therapy in acute heart failure: rationale and design of the RELAX-AHF-2 study.
Teerlink JR; Voors AA; Ponikowski P; Pang PS; Greenberg BH; Filippatos G; Felker GM; Davison BA; Cotter G; Gimpelewicz C; Boer-Martins L; Wernsing M; Hua TA; Severin T; Metra M
Eur J Heart Fail; 2017 Jun; 19(6):800-809. PubMed ID: 28452195
[TBL] [Abstract][Full Text] [Related]
8. Effect of serelaxin on cardiac, renal, and hepatic biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) development program: correlation with outcomes.
Metra M; Cotter G; Davison BA; Felker GM; Filippatos G; Greenberg BH; Ponikowski P; Unemori E; Voors AA; Adams KF; Dorobantu MI; Grinfeld L; Jondeau G; Marmor A; Masip J; Pang PS; Werdan K; Prescott MF; Edwards C; Teichman SL; Trapani A; Bush CA; Saini R; Schumacher C; Severin T; Teerlink JR;
J Am Coll Cardiol; 2013 Jan; 61(2):196-206. PubMed ID: 23273292
[TBL] [Abstract][Full Text] [Related]
9. Serelaxin for the treatment of heart failure.
Moin DS; Bloom MW; Papadimitriou L; Butler J
Expert Rev Cardiovasc Ther; 2016 Jun; 14(6):667-75. PubMed ID: 27045761
[TBL] [Abstract][Full Text] [Related]
10. Serelaxin : a potential new drug for the treatment of acute heart failure.
Neverova N; Teerlink JR
Expert Opin Investig Drugs; 2014 Jul; 23(7):1017-26. PubMed ID: 24865798
[TBL] [Abstract][Full Text] [Related]
11. Disconnect between the effects of serelaxin on renal function and outcome in acute heart failure.
Beldhuis IE; Ter Maaten JM; Figarska SM; Damman K; Pang PS; Greenberg B; Davison BA; Cotter G; Severin T; Gimpelewicz C; Felker GM; Filippatos G; Teerlink JR; Metra M; Voors AA
Clin Res Cardiol; 2023 Jul; 112(7):901-910. PubMed ID: 36656377
[TBL] [Abstract][Full Text] [Related]
12. Effects of serelaxin in patients admitted for acute heart failure: a meta-analysis.
Teerlink JR; Davison BA; Cotter G; Maggioni AP; Sato N; Chioncel O; Ertl G; Felker GM; Filippatos G; Greenberg BH; Pang PS; Ponikowski P; Edwards C; Senger S; Teichman SL; Nielsen OW; Voors AA; Metra M
Eur J Heart Fail; 2020 Feb; 22(2):315-329. PubMed ID: 31886953
[TBL] [Abstract][Full Text] [Related]
13. Relaxin for the Treatment of Acute Decompensated Heart Failure: Pharmacology, Mechanisms of Action, and Clinical Evidence.
Ng TM; Goland S; Elkayam U
Cardiol Rev; 2016; 24(4):194-204. PubMed ID: 26331289
[TBL] [Abstract][Full Text] [Related]
14. Serelaxin: insights into its haemodynamic, biochemical, and clinical effects in acute heart failure.
Hernandez AV
Eur Heart J; 2014 Feb; 35(7):410-2. PubMed ID: 24277752
[No Abstract] [Full Text] [Related]
15. Targeted biological therapies reach the heart: the case of serelaxin for heart failure.
Kumar VA; Wilson SS; Ayaz SI; Levy PD
Drugs Today (Barc); 2015 Oct; 51(10):591-7. PubMed ID: 26583301
[TBL] [Abstract][Full Text] [Related]
16. Blood Pressure Drops During Hospitalization for Acute Heart Failure Treated With Serelaxin: A Patient-Level Analysis of 4 Randomized Controlled Trials.
Grand J; Miger K; Sajadieh A; Køber L; Torp-Pedersen C; Ertl G; López-Sendón J; Pietro Maggioni A; Teerlink JR; Sato N; Gimpelewicz C; Metra M; Holbro T; Nielsen OW
Circ Heart Fail; 2022 Apr; 15(4):e009199. PubMed ID: 35184572
[TBL] [Abstract][Full Text] [Related]
17. Effect of serelaxin on mode of death in acute heart failure: results from the RELAX-AHF study.
Felker GM; Teerlink JR; Butler J; Hernandez AF; Miller AB; Cotter G; Davison BA; Filippatos G; Greenberg BH; Ponikowski P; Voors AA; Hua TA; Severin TM; Unemori E; Metra M
J Am Coll Cardiol; 2014 Oct; 64(15):1591-8. PubMed ID: 25301463
[TBL] [Abstract][Full Text] [Related]
18. Recent Progress in the Therapeutic Role of Serelaxin in Vascular Dysfunction.
Murtaza G; Siddiqui A; Hussain I
Curr Protein Pept Sci; 2018; 19(11):1079-1087. PubMed ID: 29984650
[TBL] [Abstract][Full Text] [Related]
19. Serelaxin: A Novel Therapeutic for Vascular Diseases.
Leo CH; Jelinic M; Ng HH; Tare M; Parry LJ
Trends Pharmacol Sci; 2016 Jun; 37(6):498-507. PubMed ID: 27130518
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic effects of serelaxin in acute heart failure.
Du XJ; Hewitson TD; Nguyen MN; Samuel CS
Circ J; 2014; 78(3):542-52. PubMed ID: 24451687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
